Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PVLA — Palvella Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in PVLA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,658,609
+$314,192 QoQ
Shares Held
17,397
-7.5% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 197 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PVLA Over Time

Shares Held

Position Value (USD)

Derivatives in PVLA

reported options exposure · as of Jun 30, 2026
CallValue
$18,430,092
CallShares
120,600
PutValue
$11,706,012
PutShares
76,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. PVLA ranks #73 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PVLA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,658,609 17,397
2026-06-30 $11,706,012 76,600
2026-06-30 $18,430,092 120,600
2026-03-31 $17,650,440 141,600
2026-03-31 $2,344,417 18,808
2026-03-31 $4,051,125 32,500
2025-12-31 $3,998,394 38,200
2025-09-30 $984,233 15,700
2025-09-30 $319,719 5,100
2025-09-30 $502,021 8,008
2025-06-30 $223,146 9,900
2025-06-30 $391,835 17,384
2025-03-31 $3,201,720 114,388